Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis
Lichen Ouyang, Jie Gong, Muqing Yu
International Immunopharmacology (2021) Vol. 100, pp. 108145-108145
Open Access | Times Cited: 21

Showing 21 citing articles:

Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 70
Idiopathic Pulmonary Fibrosis and Post-COVID-19 Lung Fibrosis: Links and Risks
Filippo Patrucco, Paolo Solidoro, Francesco Gavelli, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 895-895
Open Access | Times Cited: 32
Risk factors associated with COVID‐19 pneumonia in Chinese patients with pre‐existing interstitial lung disease during the SARS‐CoV‐2 pandemic
Chi Shao, Yujie Shi, Ruxuan Chen, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 9
Open Access | Times Cited: 11
Outcome of COVID-19 in patients with idiopathic inflammatory myopathy during the Omicron wave in China: A longitudinal observational study
Ying Li, Xiaolan Tian, Chao Sun, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0317319-e0317319
Open Access
Impact of Pulmonary Comorbidities on COVID-19: Acute and Long-Term Evaluations
G Mara, Gheorghe Nini, Coralia Cotoraci
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1446-1446
Open Access
Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity
Mizanur Rahman, Martin Irmler, Sandeep Keshavan, et al.
Viruses (2021) Vol. 13, Iss. 12, pp. 2537-2537
Open Access | Times Cited: 18
Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study
Elisa Martínez-Besteiro, María Molina‐Molina, Anna Michela Gaeta, et al.
Archivos de Bronconeumología (2023) Vol. 59, Iss. 4, pp. 273-276
Open Access | Times Cited: 7
Interstitial lung disease independently associated with higher risk for COVID-19 severity and mortality: A meta-analysis of adjusted effect estimates
Ying Wang, Yuqing Hao, Mengke Hu, et al.
International Immunopharmacology (2022) Vol. 111, pp. 109088-109088
Open Access | Times Cited: 11
Importance of Vaccination against SARS-CoV-2 in Patients with Interstitial Lung Disease Associated with Systemic Autoimmune Disease
Natalia Mena‐Vázquez, Aimara García-Studer, M. Rojas-Giménez, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 9, pp. 2437-2437
Open Access | Times Cited: 9
Mortality rates from asbestos-related diseases in Italy during the first year of the COVID-19 pandemic
Lucia Fazzo, Enrico Grande, Amerigo Zona, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 1
Tofacitinib and pirfenidone as rescue therapies for severe COVID‐19 in a patient with previously stable interstitial lung disease associated with Sjögren syndrome
Yu‐Chuan Tsao, Shih‐Han Chuang, Chih‐Wei Tseng
International Journal of Rheumatic Diseases (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 3
Pulmonary Fibrosis in the Time of COVID-19
Ivette Buendía-Roldán, Claudia Valenzuela, Moisés Selman
Archivos de Bronconeumología (2022) Vol. 58, pp. 6-7
Open Access | Times Cited: 5
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data
Ali Vaeli Zadeh, Roshan Dinparastisaleh, Atefeh Vaezi, et al.
Annals of the American Thoracic Society (2023) Vol. 21, Iss. 3, pp. 428-437
Open Access | Times Cited: 2
Severity and Situation of Asbestosis in the Era of COVID-19 Pandemic: A Systematic Review and Meta-Analysis
Attapon Cheepsattayakorn
Virology & Immunology Journal (2024) Vol. 8, Iss. 1, pp. 1-5
Open Access
COVID-19 in patients with interstitial lung disease
Eirini Vasarmidi, Pierre Le Guen, Tiphaine Goletto, et al.
European Respiratory Society eBooks (2024)
Closed Access
The impact of COVID-19 infection on idiopathic pulmonary fibrosis mortality: a systematic review and meta-analysis
Davide Cavasin, Umberto Zanini, Laura Montelisciani, et al.
Monaldi Archives for Chest Disease (2024)
Open Access
Midterm Effects of SARS-CoV-2 on Respiratory Function in Judokas With and Without Exercise-Induced Bronchoconstriction: A Retrospective Study
Özgür Bostancı, Emre Karaduman, Ali Kerim Yılmaz, et al.
Clinical Journal of Sport Medicine (2024)
Closed Access
Frequency of subclinical interstitial lung disease in COVID-19 autopsy cases: potential risk factors of severe pneumonia
Hiromichi Iwashita, Yoshinori Kawabata, Hiroyuki Hayashi, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 1
COVID‐19 in patients with persistent tachypnea of infancy
Honorata Marczak, Joanna Chruściel, Marek Kulus, et al.
Pediatric Pulmonology (2022) Vol. 58, Iss. 3, pp. 934-940
Open Access | Times Cited: 1
Frequency of slight interstitial lung lesions in coronavirus disease 2019 autopsy cases - potential risk factor of severe pneumonia
Hiromichi Iwashita, Yoshinori Kawabata, Hiroyuki Hayashi, et al.
Research Square (Research Square) (2023)
Open Access
Estudio de sobrevida a largo plazo en pacientes adultos con enfermedades respiratorias crónicas atendidos por infección respiratoria aguda por coronavirus SARS-CoV-2
Fernando Saldías P, Denisse Camhi B., Amanda Guzmán Z., et al.
Revista chilena de enfermedades respiratorias (2023) Vol. 39, Iss. 3, pp. 203-215
Open Access
Page 1

Scroll to top